No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:31350000-31359600 |
Weak transcription |
Pancreas |
Pancrea
|
2 |
chr2:31351600-31359600 |
Weak transcription |
Primary hematopoietic stem cells short term culture |
blood
|
3 |
chr2:31353400-31359600 |
Weak transcription |
Spleen |
Spleen
|
4 |
chr2:31358600-31359600 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
5 |
chr2:31358800-31359600 |
Active TSS |
Breast Myoepithelial Primary Cells |
Breast
|
6 |
chr2:31358800-31359800 |
Enhancers |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
7 |
chr2:31359000-31359600 |
Enhancers |
Brain Germinal Matrix |
brain
|
8 |
chr2:31359200-31359600 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
9 |
chr2:31359200-31359600 |
Active TSS |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
10 |
chr2:31359200-31359800 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
11 |
chr2:31359200-31359800 |
Flanking Active TSS |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
12 |
chr2:31359200-31359800 |
Flanking Active TSS |
HMEC |
breast
|
13 |
chr2:31359200-31360000 |
Flanking Active TSS |
NHEK |
skin
|
14 |
chr2:31359200-31360400 |
Flanking Active TSS |
Primary neutrophils fromperipheralblood |
blood
|
15 |
chr2:31359400-31359600 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
16 |
chr2:31359400-31359600 |
Bivalent Enhancer |
Primary hematopoietic stem cells |
blood
|
17 |
chr2:31359400-31359600 |
Bivalent Enhancer |
Duodenum Mucosa |
Duodenum
|
18 |
chr2:31359400-31359600 |
Active TSS |
Esophagus |
oesophagus
|
19 |
chr2:31359400-31359800 |
Active TSS |
Fetal Brain Female |
brain
|
20 |
chr2:31359400-31360600 |
Bivalent Enhancer |
Primary T cells effector/memory enriched fromperipheralblood |
blood
|
21 |
chr2:31359400-31361600 |
Bivalent/Poised TSS |
Primary T cells from cord blood |
blood
|
22 |
chr2:31359400-31361800 |
Active TSS |
A549 |
lung
|